| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
4,662,221 | 4,303,702 | 3,897,504 | 3,660,953 | 3,367,324 |
| Cost of Revenue
|
-1,737,983 | -1,644,123 | -1,518,577 | -1,470,983 | -1,362,986 |
|
Gross Profit
|
2,924,238 | 2,659,579 | 2,378,927 | 2,189,970 | 2,004,338 |
| Selling, General and Administrative Expenses
|
-1,151,266 | -1,048,341 | -1,030,798 | -901,891 | -850,753 |
|
Research and Development Expenses
|
-266,867 | -251,207 | -219,792 | -190,951 | -254,820 |
|
Operating Income/Expenses
|
-1,418,133 | -1,299,548 | -1,250,590 | -1,092,842 | -1,105,573 |
|
Total Operating Profit/Loss
|
1,506,105 | 1,360,031 | 1,128,337 | 1,097,128 | 898,765 |
| Total Net Finance Income/Expense
|
-31,835 | -35,842 | -18,506 | -35,952 | -38,793 |
|
Non-Operating Income/Expenses, Total
|
-27,132 | -35,842 | -18,506 | -35,952 | -38,793 |
|
Pretax Income
|
1,478,973 | 1,324,189 | 1,109,831 | 1,061,176 | 859,972 |
|
Provision for Income Tax
|
-296,782 | -264,725 | -221,964 | -216,134 | -180,883 |
|
Net Income from Continuing Operations
|
1,182,191 | 1,059,464 | 887,867 | 845,042 | 679,089 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
1,182,191 | 1,059,464 | 887,867 | 845,042 | 679,089 |
|
Non-Controlling/Minority Interests
|
-- | -- | -- | 0 | 0 |
|
Net Income after Non-Controlling/Minority Interests
|
1,182,191 | 1,059,464 | 887,867 | 845,042 | 679,089 |
|
Net Income Available to Common Stockholders
|
1,182,191 | 1,059,464 | 887,867 | 845,042 | 679,089 |
|
Diluted Net Income Available to Common Stockholders
|
1,182,191 | 1,059,464 | 887,867 | 845,042 | 679,089 |
| Basic EPS
|
14.91 | 13.17 | 10.77 | 10.17 | 8.12 |
| Diluted EPS
|
14.83 | 13.08 | 10.67 | 10.06 | 8.03 |
|
Basic Weighted Average Shares Outstanding
|
79,327.50 | 80,427 | 82,467 | 83,066 | 83,623 |
|
Diluted Weighted Average Shares Outstanding
|
79,753.75 | 81,025 | 83,246 | 83,978 | 84,600 |
|
Reported Normalized Diluted EPS
|
14.24 | 12.55 | 10.99 | 10.14 | 8.10 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
1,510,808 | 1,360,031 | 1,128,337 | 1,097,128 | 898,765 |
|
EBITDA
|
1,668,826 | 1,505,214 | 1,258,273 | 1,212,036 | 1,010,665 |
|
Normalized EBITDA
|
1,733,581 | 1,569,147 | 1,331,721 | 1,278,915 | 1,062,373 |
|
Normalized Income
|
1,233,951.74 | 1,107,474.40 | 936,103 | 892,594.24 | 720,260.64 |
|
Total Unusual Items
|
64,755 | 60,013 | 60,295 | 59,739 | 52,116 |
|
Total Unusual Items Excluding Goodwill
|
64,755 | 60,013 | 60,295 | 59,739 | 52,116 |
|
Tax Effect of Unusual Items
|
12,994.26 | 12,002.60 | 12,059 | 12,186.76 | 10,944.36 |
12/31/2022 - 6/21/1991
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade